The International Journal of Green Nanotechnology is a unique open access journal addressing important challenges and latest advances in the chemistry, physics, biology, engineering, and other scientific aspects of green nanotechnology as well as on their societal impact and the policies that have been or should be developed to address them. It has three primary foci: biomedicine, materials science and engineering, and physics and chemistry. This journal is a member of the Committee on Publication Ethics (COPE).
The rapid growth of interest in medicinal mushrooms research is matched by the large number of disparate groups that currently publish in a wide range of publications. The International Journal of Medicinal Mushrooms is the one source of information that will draw together all aspects of this exciting and expanding field - a source that will keep you up to date with the latest issues and practice. The International Journal of Medicinal Mushrooms published original research articles and critical reviews on a broad range of subjects pertaining to medicinal mushrooms, including systematics, nomenclature, taxonomy, morphology, medicinal value, biotechnology, and much more. Papers on new techniques that might promote experimental progress in the aforementioned field are also welcomed. In addition to full-length reports of original research, the journal publishes short communications and interesting case reports, together with literature reviews. Letters to the editor on topics of interest to readers are also published.
The International Journal of Nanomedicine is an international, peer-reviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Reflecting the growing activity in this emerging specialty, the aim of this journal is to highlight research and development leading to potential clinical applications in the prevention and treatment of disease.
clinical application, or which provides insights into the biological basis of neuropsychiatric disorders and thereby advances their pharmacological treatment. Such research might derive from the full spectrum of biological and psychological fields of inquiry, encompassing classical and novel techniques in neuropsychopharmacology, as well as strategies such as neuroimaging, genetics, psycho-neuroendocrinology and neuropsychology. IJNP's rapid publication policy is facilitated by web-based submission and review, and the journal publishes the definitive versions of papers online, ahead of the printed issues. All papers are indexed in PubMed and Thomson Reuters Journal Citation Reports.
The International Journal of Peptide Research and Therapeutics publishes the latest developments in peptide therapeutics and high quality research covering all aspects of peptide science. The journal brings together in a single source the most exciting peer-reviewed work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives.Coverage includes new advances in peptide drug delivery systems; application of peptide therapeutics to specific diseases; advances in synthetic methods; development of new procedures for construction of peptide libraries and methodology for screening of such mixtures; the use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions; applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.IJPRT requests that all authors comply to
The International Journal of Pharmaceutics is the journal for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial PolicyThe over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.
International Journal of Pharmacology is a peer-reviewed well indexed scientific journal dedicated to publish the significant research findings in all areas of pharmacology and related disciplines. Scope of the journal covers: behavioral pharmacology, neuro-pharmacology and analgesia, cardiovascular pharmacology, pulmonary, gastrointestinal and urogenital pharmacology, endocrine pharmacology, immune-pharmacology and inflammation and molecular and cellular pharmacology. International Journal of Pharmacology now accepting new submissions. Submit your best paper via online submission system.
International Journal of Pharmacy Practice (IJPP) publishes original research and review articles on all aspects of medicines management, policy, practice and education. Topics covered include:.
The International Journal of Toxicology publishes timely, peer-reviewed papers on current topics important to toxicologists. Six bi-monthly issues cover a wide range of topics, including contemporary issues in toxicology, safety assessments, novel approaches to toxicological testing, mechanisms of toxicity, biomarkers, and risk assessment. The Journal also publishes invited reviews on contemporary topics, and features articles based on symposia. In addition, supplemental issues are routinely published on various special topics, including three supplements devoted to contributions from the Cosmetic Review Expert Panel. The Journal does not have submission or publication fees, and color pages are now available at a greatly reduced price.
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.
Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results.
Investigatio
The journal of "IJBMS" is a modern forum for scientific communication. Data and information that are useful to investigators in any discipline in basic medical sciences mainly including anatomical sciences, biochemistry, genetics, immunology, microbiology, pathology, pharmacology, pharmaceutical sciences, and physiology will be published after they have been peer reviewed. This will also include reviews and multidisciplinary research.